Vipivotide tetraxetan is intended for Pharmaceuticals applications and is used for the treatment of prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC). All information about Vipivotide tetraxetan is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. Connect to your member account to consult the documents.

规格	1 mg
稳定性	≥ 1 year